BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 29473508)

  • 1. Tolfenamic Acid Prevents Amyloid β-induced Olfactory Bulb Dysfunction In Vivo.
    Cornejo-Montes-de-Oca JM; Hernández-Soto R; Isla AG; Morado-Urbina CE; Peña-Ortega F
    Curr Alzheimer Res; 2018; 15(8):731-742. PubMed ID: 29473508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in Piriform and Bulbar Activity/Excitability/Coupling Upon Amyloid-β Administration in vivo Related to Olfactory Dysfunction.
    Martínez-García I; Hernández-Soto R; Villasana-Salazar B; Ordaz B; Peña-Ortega F
    J Alzheimers Dis; 2021; 82(s1):S19-S35. PubMed ID: 33459655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exercise Prevents Amyloid-β-Induced Hippocampal Network Disruption by Inhibiting GSK3β Activation.
    Isla AG; Vázquez-Cuevas FG; Peña-Ortega F
    J Alzheimers Dis; 2016 Mar; 52(1):333-43. PubMed ID: 27003207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sudden Intrabulbar Amyloid Increase Simultaneously Disrupts Olfactory Bulb Oscillations and Odor Detection.
    Hernández-Soto R; Rojas-García KD; Peña-Ortega F
    Neural Plast; 2019; 2019():3424906. PubMed ID: 31531013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oligomeric amyloid-β peptide disrupts olfactory information output by impairment of local inhibitory circuits in rat olfactory bulb.
    Hu B; Geng C; Hou XY
    Neurobiol Aging; 2017 Mar; 51():113-121. PubMed ID: 28061384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyloid beta inhibits olfactory bulb activity and the ability to smell.
    Alvarado-Martínez R; Salgado-Puga K; Peña-Ortega F
    PLoS One; 2013; 8(9):e75745. PubMed ID: 24086624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of GSK3β in odor habituation and spontaneous neural activity of the mouse olfactory bulb.
    Xu Z; Wang L; Chen G; Rao X; Xu F
    PLoS One; 2013; 8(5):e63598. PubMed ID: 23658842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tolfenamic acid interrupts the de novo synthesis of the β-amyloid precursor protein and lowers amyloid beta via a transcriptional pathway.
    Adwan LI; Basha R; Abdelrahim M; Subaiea GM; Zawia NH
    Curr Alzheimer Res; 2011 Jun; 8(4):385-92. PubMed ID: 21557719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An early dysregulation of FAK and MEK/ERK signaling pathways precedes the β-amyloid deposition in the olfactory bulb of APP/PS1 mouse model of Alzheimer's disease.
    Lachén-Montes M; González-Morales A; de Morentin XM; Pérez-Valderrama E; Ausín K; Zelaya MV; Serna A; Aso E; Ferrer I; Fernández-Irigoyen J; Santamaría E
    J Proteomics; 2016 Oct; 148():149-58. PubMed ID: 27498392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic intermittent hypoxia alters main olfactory bulb activity and olfaction.
    Hernández-Soto R; Villasana-Salazar B; Pinedo-Vargas L; Peña-Ortega F
    Exp Neurol; 2021 Jun; 340():113653. PubMed ID: 33607078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incensole acetate prevents beta-amyloid-induced neurotoxicity in human olfactory bulb neural stem cells.
    El-Magd MA; Khalifa SF; A Alzahrani FA; Badawy AA; El-Shetry ES; Dawood LM; Alruwaili MM; Alrawaili HA; Risha EF; El-Taweel FM; Marei HE
    Biomed Pharmacother; 2018 Sep; 105():813-823. PubMed ID: 29913410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancing GABAergic signaling ameliorates aberrant gamma oscillations of olfactory bulb in AD mouse models.
    Chen M; Chen Y; Huo Q; Wang L; Tan S; Misrani A; Jiang J; Chen J; Chen S; Zhang J; Tabassum S; Wang J; Chen X; Long C; Yang L
    Mol Neurodegener; 2021 Mar; 16(1):14. PubMed ID: 33663578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early in vivo Effects of the Human Mutant Amyloid-β Protein Precursor (hAβPPSwInd) on the Mouse Olfactory Bulb.
    Rusznák Z; Kim WS; Hsiao JH; Halliday GM; Paxinos G; Fu Y
    J Alzheimers Dis; 2016; 49(2):443-57. PubMed ID: 26484907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interneurons and beta-amyloid in the olfactory bulb, anterior olfactory nucleus and olfactory tubercle in APPxPS1 transgenic mice model of Alzheimer's disease.
    Saiz-Sanchez D; De La Rosa-Prieto C; Ubeda-Bañon I; Martinez-Marcos A
    Anat Rec (Hoboken); 2013 Sep; 296(9):1413-23. PubMed ID: 23904197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. History-Dependent Odor Processing in the Mouse Olfactory Bulb.
    Vinograd A; Livneh Y; Mizrahi A
    J Neurosci; 2017 Dec; 37(49):12018-12030. PubMed ID: 29109236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of amyloid-β deposition and attenuation of memory deficits by tolfenamic acid.
    Subaiea GM; Ahmed AH; Adwan LI; Zawia NH
    J Alzheimers Dis; 2015; 43(2):425-33. PubMed ID: 25096618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tolfenamic acid is a potent CYP1A2 inhibitor in vitro but does not interact in vivo: correction for protein binding is needed for data interpretation.
    Karjalainen MJ; Neuvonen PJ; Backman JT
    Eur J Clin Pharmacol; 2007 Sep; 63(9):829-36. PubMed ID: 17618427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postnatal Odor Exposure Increases the Strength of Interglomerular Lateral Inhibition onto Olfactory Bulb Tufted Cells.
    Geramita M; Urban NN
    J Neurosci; 2016 Dec; 36(49):12321-12327. PubMed ID: 27927952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA polymerase β decrement triggers death of olfactory bulb cells and impairs olfaction in a mouse model of Alzheimer's disease.
    Misiak M; Vergara Greeno R; Baptiste BA; Sykora P; Liu D; Cordonnier S; Fang EF; Croteau DL; Mattson MP; Bohr VA
    Aging Cell; 2017 Feb; 16(1):162-172. PubMed ID: 27686631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Olfaction: New Understandings, Diagnostic Applications.
    Ruggiero GF; Wick JY
    Consult Pharm; 2016 Nov; 31(11):624-632. PubMed ID: 28107119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.